1. World health organization. WHO; 2020 [Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200725-covid-19-sitrep-187.pdf?sfvrsn=1ede1410_2.
2. Kim HN, Lee JH, Park HS, Yang DH, Jang SY, Bae MH, et al. A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock. J Korean Med Sci. 2020;35(27):e258-e.
3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.
4. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA cardiology. 2020;5(7):1-8.
5. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA cardiology. 2020;5(7):802-10.
6. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.
7. Ong E, Castro-Dominguez Y, Brennan J, Oen-Hsiao J. COVID-19 complicated by ST-segment elevation myocardial infarction in a 29-year-old patient. Catheterization and Cardiovascular Interventions. 2020;n/a(n/a).
8. Dabbagh MF, Aurora L, D’Souza P, Weinmann AJ, Bhargava P, Basir MB. Cardiac Tamponade Secondary to COVID-19. JACC: Case Reports. 2020;2(9):1326.
9. Monmeneu JV, Dominguez Mafe E, Andres Soler J, Ventura Perez B, Solsona Caravaca J, Broseta Torres R, et al. Subacute perimyocarditis in a young patient with COVID-19 infection. European Heart Journal - Case Reports. 2020.
10. Dominguez-Erquicia P, Dobarro D, Raposeiras-Roubín S, Bastos-Fernandez G, Iñiguez-Romo A. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. European heart journal. 2020;41(22):2132.
11. Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M, et al. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation. 2020;141(25):2113-6.
12. Reynolds HR, Srichai MB, Iqbal SN, Slater JN, Mancini GBJ, Feit F, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011;124(13):1414-25.
13. Gehrie ER, Reynolds HR, Chen AY, Neelon BH, Roe MT, Gibler WB, et al. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J. 2009;158(4):688-94.
14. Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio ALP, et al. ESC working group position paper on myocardial infarction with nonobstructive coronary arteries. European heart journal. 2016;38(3):143-53.
15. Nakayama N, Kaikita K, Fukunaga T, Matsuzawa Y, Sato K, Horio E, et al. Clinical features and prognosis of patients with coronary spasm-induced non-ST-segment elevation acute coronary syndrome. J Am Heart Assoc. 2014;3(3):e000795-e.
16. Gharacholou SM, Ijioma N, Banwart E, Munoz FDC. ST-Segment Elevation Myocardial Infarction and Normal Coronary Arteries after Consuming Energy Drinks. Case Rep Cardiol. 2017;2017:4061205-.
17. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40.